NCT04005157

ENB Guided MWA for Early-stage Peripheral Lung Cancer

A Multi-center Study of Electromagnetic Navigation Bronchoscopy (ENB) Guided Microwave Ablation for Early-stage Peripheral Lung Cancer

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Shanghai Chest Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of the study was to evaluate the efficacy and safety of electromagnetic navigation bronchoscopy (ENB) guided microwave ablation (MWA) for the treatment of early-stage peripheral lung cancer.

Detailed description

The study is designed as a multi-center prospective trial with one arm. There will be 5 centers participating the study. Patients diagnosed with early-stage non-small cell lung cancer (NSCLC) that are nonsurgical candidate will be enrolled in the study. Sixty patients are expected to be enrolled in the study. The purpose of the study is to evaluate the efficacy and safety of ENB guided MWA for the treatment of patients with early-stage nonsurgical NSCLC.

Conditions

• Lung Cancer

Interventions

Type	Name	Description
PROCEDURE	MWA	Patients diagnosed with early-stage NSCLC and signing the informed consent will undergo MWA with the guidance of ENB.
DEVICE	ENB	ENB (LungCare Medical Technologies Ltd., Inc, Suzhou, China)will be used to guide bronchoscope into the accurate location of the lesion during MWA.

Timeline

• Start date: 2018-04-18
• Primary completion: 2020-06-01
• Completion: 2020-06-01
• First posted: 2019-07-02
• Last updated: 2020-01-10

Locations

1 site across 1 country: China